Baxter Reports Second-Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
Go back to Baxter Reports Second-Quarter 2022 Results
July 28, 2022 9:57 AM EDT
Stifel analyst Rick Wise reiterated a Buy rating and $75.00 price target on Baxter International (NYSE: BAX)
The analyst comments "Macro challenges have been very much in evidence during initial 2Q22 MedTech reports. In Baxters 2Q, we are seeing the most significant negative... More
July 28, 2022 9:55 AM EDT
Evercore ISI analyst Vijay Kumar reiterated an Outperform rating and $80.00 price target on Baxter International (NYSE: BAX).
The analyst comments "BAX reported organic rev growth of ~3%, which came in ~1% below Guide expectations. Total revs of $3.74 Bn came 3% below ST, and incl Fx impact of -500 bps (we are unsure... More
July 28, 2022 9:53 AM EDT
KeyBanc analyst Matthew Mishan reiterated an Overweight rating and $87.00 price target on Baxter International (NYSE: BAX).
The analyst comments "We believe investors will view BAXs 2Q22 release and updated 2022 guidance as disappointing. 2Q revenue missed mostly on FX and weaker... More
July 28, 2022 7:25 AM EDT
Baxter (NYSE: BAX) reported Q2 EPS of $0.87, in-line with the analyst estimate of $0.87. Revenue for the quarter came in at $3.75 billion versus the consensus estimate of $3.88 billion.
GUIDANCE:
Baxter sees FY2022 EPS of $3.60-$3.70, versus the consensus of $4.13.
For earnings history and earnings-related data on Baxter (BAX) click here.
...
More
